Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07224035 | Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1 | active not recruiting | Phase 4 | 500 | University of MiamiOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07224048 | Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 | active not recruiting | Phase 4 | 75 | University of MiamiOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05634720 |
| Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer |
| active not recruiting |
| Phase 4 |
| 20 |
| Duke UniversityOTHER |
| 1 |
| Jan 26, 2026 |
| clinicaltrials |
| NCT04025840 | Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery | active not recruiting | Phase 4 | 260 | Peking University First HospitalOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07020468 | Neoadjuvant Therapy (NALIRIFOX) for Locally Advanced Colon and Upper Rectal Cancer(HOPE) | active not recruiting | Phase 4 | 57 | Affiliated Cancer Hospital of Shantou University Medical CollegeOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT03024684 | Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment(SHOT) | active not recruiting | Phase 4 | 240 | Chiayi Christian HospitalOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT04281667 | Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery(MOBILE2) | active not recruiting | Phase 4 | 604 | Helsinki University Central HospitalOTHER | 1 | Nov 17, 2022 | clinicaltrials |
| NCT02775227 | HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications(HYPAR) | active not recruiting | Phase 4 | 126 | Helsinki University Central HospitalOTHER | 1 | Aug 24, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Feb 17, 2026source: clinicaltrials